Formulary Digital Edition April 2010

News
Article

Reducing cardiovascular risk is patients with type 2 diabetes: management of dyslipidemia; Focus on naproxicond; Drug Watch: Agents in late-stage development for the treatment of hepatitis C

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.